U.S. markets open in 4 hours 6 minutes

Rite Aid Corporation (RAD)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
18.01+0.23 (+1.29%)
At close: 4:00PM EDT

18.19 +0.18 (1.00%)
Pre-Market: 4:07AM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close17.78
Open17.75
Bid17.25 x 900
Ask18.65 x 800
Day's Range17.58 - 18.53
52 Week Range8.86 - 32.48
Volume1,662,893
Avg. Volume2,183,885
Market Cap992.382M
Beta (5Y Monthly)0.83
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateOct 14, 1999
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Rite Aid says mask-wearing due to COVID-19 drove down cold- and flu-related sales by 37%
    MarketWatch

    Rite Aid says mask-wearing due to COVID-19 drove down cold- and flu-related sales by 37%

    Rite Aid Corp. (RAD) said it saw a 37% decline in sales of items related to colds and the flu during the fourth quarter, thanks to safety precautions taken to combat the COVID-19 pandemic. “This decline was greater than we anticipated and was, of course, driven by everyone continuing to mask up and also certainly from kids not being back socializing at school,” said Heyward Donigan, Rite Aid chief executive, on last week’s earnings call, according to FactSet. Rite Aid wasn’t the only pharmacy retailer to report a sharp decline in cold-and flu-related items during the quarter.

  • Rite Aid's (RAD) Q4 Loss Narrower Than Expected, Sales Beat
    Zacks

    Rite Aid's (RAD) Q4 Loss Narrower Than Expected, Sales Beat

    Rite Aid's (RAD) Q4 results gain from RxEvolution strategy, strength in Elixir brand and robust online growth. However, COVID-related costs woes and lesser cases of cough, cold and flu are concerns.

  • Rite Aid (RAD) Q4 2021 Earnings Call Transcript
    Motley Fool

    Rite Aid (RAD) Q4 2021 Earnings Call Transcript

    RAD earnings call for the period ending March 31, 2021.